GGrantIndex
Sort

130,381 grants matching hiv

IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND TREATMENT

$912,964
Dr. Meshack Wanjuki · African Medical And Research Foundation · U2G · FY2012 · PS

inter epi.research studies to reduce mother to child HIV-1 trans

$912,951
Newton Isaac Kumwenda · University Of Malawi · U50 · FY2007 · PS

Structure-Based Design of Drugs and Vaccines for Target*

$912,946
Rutgers The St Univ Of Nj New Brunswick · P01 · FY2004 · GM

Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection

$912,893
John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2019 · AI

Administrative Core

$912,861
Susan Little · University Of California, San Diego · P01 · FY2009 · AI

Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies

$912,815
Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2020 · AI

Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses

$912,779
Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2006 · AI

Suubi+Adherence-R2: Examining the longitudinal HIV treatment adherence among youth living with HIV (YLHIV) transitioning into young adulthood

$912,766
Fred M Ssewamala · Washington University · R01 · FY2023 · HD

Heavy cannabis use, neurocognition and PrEP care engagement among young Black sexual minority men

$912,755
John Schneider · University Of Chicago · R01 · FY2023 · DA

Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV

$912,596
Michael B Zwick · Scripps Research Institute, The · R01 · FY2025 · AI

Platelet Exocytosis and Endocytosis in Thrombosis and Immunity

$912,539
Sidney Waldo Whiteheart · University Of Kentucky · R35 · FY2024 · HL

HIV-Receptor Interactions and Related Anti-HIV Strategies

$912,524
Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

EXPANSION OF HIV PREVENTION COUNSELING, PSYCHOSOCIAL SUPPORT AND OUTREACH SERVICE

$912,500
Mike Merrigan · Academy For Educational Development · U2G · FY2009 · PS

EXPANSION OF HIV PREVENTION COUNSELING, PSYCHOSOCIAL SUPPORT AND OUTREACH SERVICE

$912,500
Mike Merrigan · Academy For Educational Development · U2G · FY2010 · PS

EXPANSION OF HIV PREVENTION COUNSELING, PSYCHOSOCIAL SUPPORT AND OUTREACH SERVICE

$912,500
Sinah Chaba · Pathfinder International, Inc. · U2G · FY2009 · PS

EXPANSION OF HIV PREVENTION COUNSELING, PSYCHOSOCIAL SUPPORT AND OUTREACH SERVICE

$912,500
Sinah Chaba · Pathfinder International, Inc. · U2G · FY2010 · PS

Clinical Trials Network: Greater New York Node

$912,450
Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2013 · DA

Immune Responses To HIV And Other Pathogens

$912,355
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain

$912,344
Joanne Wang · University Of Washington · UC2 · FY2024 · HD

Stanford AIDS Clinical Trials Unit

$912,290
Andrew Zolopa · Stanford University · U01 · FY2009 · AI

Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers

$912,255
D. Noah Sather · Seattle Children'S Hospital · R01 · FY2019 · AI

Descending Modulation of Nerve Injury and Injury-Evoked Pain

$912,180
Marisela Morales · National Institute On Drug Abuse · ZIA · FY2012 · DA

ADOLESCENT MEDICINE TRIALS UNIT AT CHOP

$912,102
Children'S Hospital Of Philadelphia · U01 · FY2003 · HD

Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder

$912,089
Cathy J Reback · Friends Research Institute, Inc. · R01 · FY2024 · DA

Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates

$911,877
Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2020 · AI